Daiwa Securities Group
GRCL

Daiwa Securities Group’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Daiwa Securities Group’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-146
Closed -$1K – 1367
2023
Q4 		$1K Hold
146
– – ﹤0.01% 1316
2023
Q3 		$0 Hold
146
– – ﹤0.01% 1353
2023
Q2 		$1K Hold
146
– – ﹤0.01% 1314
2023
Q1 		$0 Hold
146
– – ﹤0.01% 1332
2022
Q4 		$0 Hold
146
– – ﹤0.01% 1413
2022
Q3 		$0 Hold
146
– – ﹤0.01% 1420
2022
Q2 		$1K Hold
146
– – ﹤0.01% 1337
2022
Q1 		$0 Sell
146
-2,307
-94% -$7.86K ﹤0.01% 1435
2021
Q4 		$15K Sell
2,453
-2,311
-49% -$22.2K ﹤0.01% 1133
2021
Q3 		$66K Buy
+4,764
New +$56.2K ﹤0.01% 1026

Daiwa Securities Group's GRCL Position: Q1 2024 in Review

Daiwa Securities Group sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2024, closing a stake of 146 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in GRCL in Q3 2021 and held it in 10 quarters. The position peaked at $66K in Q3 2021. 0 funds tracked by Wall St. Rank hold GRCL as of Q1 2024.

  • Daiwa Securities Group reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Daiwa Securities Group sold 146 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2024, an estimated $1K.
  • Daiwa Securities Group first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q3 2021 and held it in 10 quarters.
  • Daiwa Securities Group's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $66K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2024.

Based on Daiwa Securities Group's 13F filing for Q1 2024, filed 2 May 2024.